Cymbria Vs. NovoCure Industry Stock Comparison

Sell

48

CYMBF
Cymbria

Last Price:

$52.12

Seasonality Move:

3.35%

Sell

49

NVCR
NovoCure

Last Price:

$30.18

Seasonality Move:

-3.69%

Sell

48

Cymbria (CYMBF) is a Sell

Is Cymbria a Buy, Sell or Hold?

The current Cymbria [CYMBF] share price is $52.12. The Score for CYMBF is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
CYMBF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Sell

49

NovoCure (NVCR) is a Sell

Is NovoCure a Buy, Sell or Hold?

The current NovoCure [NVCR] share price is $30.19. The Score for NVCR is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
NVCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CYMBF Stock Price Chart

What is Cymbria's stock price today?

The Cymbria share price today is $52.12

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYMBF is experiencing slight buying pressure.

NVCR Stock Price Chart

What is NovoCure's stock price today?

The NovoCure share price today is $30.19

The current trend is moderately bullish and NVCR is experiencing slight selling pressure.

CYMBF Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.15	Sell
Relative Strength Index (14 RSI):	23.4	Sell
Chaikin Money Flow:	0	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(52.14 - 52.9)	Sell
Bollinger Bands (100):	(49.36 - 53)	Buy

NVCR Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	1.94	Buy
Relative Strength Index (14 RSI):	58.79	Buy
Chaikin Money Flow:	-60501	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(26.36 - 32.64)	Buy
Bollinger Bands (100):	(14.38 - 25.86)	Buy

CYMBF Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	52.12	Sell
20-day SMA:	52.43	Sell
50-day SMA:	52.52	Sell
200-day SMA:	49.54	Buy
8-day EMA:	52.16	Sell
20-day EMA:	52.34	Sell
50-day EMA:	52.18	Sell
200-day EMA:	0.52	Buy

NVCR Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	30.52	Sell
20-day SMA:	30.41	Sell
50-day SMA:	23.25	Buy
200-day SMA:	18.89	Buy
8-day EMA:	30.36	Sell
20-day EMA:	29.22	Buy
50-day EMA:	25.18	Buy
200-day EMA:	21.21	Buy

Cymbria Earnings Growth & CYMBF Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

NovoCure Earnings Growth & NVCR Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.31 per share, and an increase next year of $0.06 per share.

Cymbria Technical Analysis

	Dec 19	Dec 20	Dec 23	Dec 24	Dec 26	Dec 27	Dec 30	Dec 31	Jan 2	Jan 3
	Dec									Jan
	19	20	23	24	26	27	30	31	02	03
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovoCure Technical Analysis

	Dec 19	Dec 20	Dec 23	Dec 24	Dec 26	Dec 27	Dec 30	Dec 31	Jan 2	Jan 3
	Dec									Jan
	19	20	23	24	26	27	30	31	02	03
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):